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Abstract 
Background: Infantile eczema is an immunological disease that is characterized by itchy and dry skin. Recent studies 
have suggested that gut microbiota (GM) plays a role in the development and progression of eczema. To further eval-
uate this potential link, we collected feces from 19 infants with eczema and 14 infants without eczema and analyzed 
the molecular discrepancies between the two groups using 16S rDNA analysis.
Results: Bacteroidaceae and Deinococcaceae were significantly enriched in eczema infants, and Bacteroidaceae was 
potentially involved in autoimmune diseases by promoting the Th17 (T helper cell 17) secretion of IL-17 (interleu-
kin-17). In the infants without eczema, the co-abundance network featured three core nodes: Clostridiaceae, Veillonel-
laceae, and Lactobacillaceae, all of which were lacking in the infants with eczema. Furthermore, our data suggested 
that Enterobacteriaceae was the core of the co-abundance network for the diseased subjects.
Conclusions: GM is closely connected to the human immune system, and the dysbiotic GM network plays a role in 
eczema. This study furthered our understanding of the dynamic GM network and its correlation to the occurrence of 
eczema.
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Background
Infantile eczema is a common inflammatory skin dis-
ease with a relative morbidity of 13.5 % in China [1]. The 
pathogenesis of infantile eczema is not well understood, 
and many reports have indicated that various factors 
such as an aberrant immune system and skin barrier dys-
function may be responsible [2]. Environmental factors, 
including allergens, temperature and humidity variations, 
solarization, and microorganisms, may also contribute to 
the incidence and progression of infantile eczema [2].
Recent studies have suggested that the gut microbiota 
(GM) may correlate with infantile eczema [3–8]. A report 
by Thomas et al. found that infants with eczema harbored 
lower GM diversity compared to their healthy counter-
parts [3], and Gaik et  al. [4] and Hong et  al. [5] further 
documented discrepant microbial enrichment in healthy 
and eczema infants, wherein Bifidobacterium and Lac-
tobacillus were abundant in healthy infants [4, 5] while 
infants with eczema harbored more pathogens, includ-
ing Enterococcus, Klebsiella, and Shigella [4, 5]. Several 
reports have also shown that gut bacteria interact with 
each other and form a dynamic network that may have 
substantial effects on human health [8–12]. Besides type 
II diabetes, rheumatoid arthritis, and inflammation [9, 
10, 12], the GM network may also affect diet nutrient and 
immune systems in infants [11, 13]. Clarissa et  al. [12] 
found that the decrease of Clostridiales was accompa-
nied by the promotion of Bacteroidales, and that the up-
regulated Bacteroidales-encoded flagellin could activate 
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human immune responses [13]. To the best of our knowl-
edge, an in-depth analysis on the microbial interaction 
in infantile eczema and corresponding impact on infant 
health has not been conducted thus far.
In this investigative study, we enrolled 19 infants with 
eczema and 14 control infants without eczema and com-
pared their GM composition. Furthermore, we analyzed 
the differential microbial interaction and relative con-
tribution to infant health. The work presented herein 
may further the understanding of dysbiotic GM and its 
involvement in eczema progression.
Methods
Clinical diagnosis and sample collection
All infants’ parents provided written informed con-
sent, and this study was approved by the Ethical Com-
mittee of Shenzhen Children’s Hospital under approval 
number 2016(004). Eczema was defined as a pruritic, 
chronic, or chronically relapsing infectious dermatitis 
with typical features and distribution [14]. All infants 
with eczema had to satisfy the following inclusion cri-
teria: (1) the patients had to have a clear clinical mani-
festation of eczema; (2) the patients were not to have 
other acute and chronic diseases; (3) the skin lesions 
of patients were not to be infected by bacteria, viruses, 
or fungi; (4) the patients were required to abstain from 
ingesting antibiotics, immune modulating inhibitors, or 
probiotic drinks in the 2 weeks prior to the start of the 
study; and (5) the patients should not have had diarrhea 
in the 2  weeks prior to the start of the study. Control 
subjects (non-eczema infants) were selected from the 
subjects who passed physical examinations at Shenzhen 
Children’s Hospital and met the following criteria: (1) all 
of the infants were not to have allergic diseases or family 
history of allergic disease; (2) all subjects were required 
to abstain from ingesting antibiotics, immune modulat-
ing inhibitors, or probiotic drinks in the 2  weeks prior 
to the start of the study; and (3) selected infants should 
not have diarrhea in the 2 weeks prior to the start of the 
study.
DNA extraction, library construction, and sequencing
Microbial DNA was extracted from stool samples using 
the E.Z.N.A.® Soil DNA Kit (Omega Bio-tek, Norcross, 
GA, USA) according to the manufacturer’s protocols. 
Using the PCR kit (TransGenAP221-02), 16S rDNA 
V4-V5 regions of samples were amplified by primers 515F 
and 907R. The band widths of PCR products were then 
verified by 2 % agarose gel electrophoresis, and the qual-
ity of PCR products was detected by QuantiFluor™-ST 
(Promega Corporation). After library construction, the 
qualified libraries were used for MiSeq sequencing fol-
lowing the Paired-end 300 strategy.
Taxonomical classification and microbial diversity 
detection
Produced reads, which contained more than 10 bases 
with low quality (<Q20) or 15 bp adapter contamination, 
were removed. Tags were produced by overlapped filtered 
paired reads and clustered to get operational taxonomic 
units (OTUs) by USEARCH (v7.0.1090) [15]. OTUs with 
chimera were removed by UCHIIME (v4.2.40) [16]. Rep-
resentative OTUs were defined by mapping tags and 
produced by usearch_global (Additional file 1) [17]. Rep-
resentative OTUs were aligned with Greengenes database 
(v201305) [18], and the corresponding taxonomic posi-
tion was defined by RDP classifier (v2.2) [17] following 0.8 
confidence value. The Shannon and Simpson values were 
calculated by MOTHUR (v1.31.2) [19], which exhibited 
the richness and evenness of microbial composition.
Statistical analysis
Χ2 test was applied to evaluate the effect, if any, of gen-
der, feeding method, birthing method, and age on GM 
discrepancy. LEfSe [LDA (Linear discriminant analysis) 
Effect Size] analysis was used to identify microbial resi-
dents enriched in eczema or non-eczema infants, follow-
ing default standards: the p value of the Kruskal–Wallis 
test and the Wilcoxon test was less than 0.05, and the 
LDA score was set as 2 [20]. The co-abundance microbial 
network for eczema subjects and non-eczema counter-
parts was inferred based on the Pearson index. Pearson’s 
correlation with coefficient >0.45 or <−0.35 was selected 
for co-abundance network construction, using Cytoscape 
software (v2.2.0) [21].
Results
Sample collection and data output
The stool samples were collected from randomized 19 
eczema and 14 non-eczema infants, all of whom were 
younger than 6  months old. After 16S rDNA sequenc-
ing, the tag number of the stool samples averaged 51,158, 
with a range of 28,071–66,546. In addition, the overall 
OTUs number for 33 samples was 269, with 30–93 for 
non-eczema infants and 33–95 for eczema infants. Evalu-
ations of potential confounders, including gender, feed-
ing method, birthing method, and age, were conducted 
and all had a minimal impact on the inter-group and the 
in-group discrepancy (Table 1).
Eczema and non‑eczema infants showed no significant 
difference on gut microbial diversity
The Shannon and Simpson indices were applied to evalu-
ate microbial diversity. Based on the OTUs distribution 
(Additional file  2), the average value of Shannon was 
1.528 ± 0.240 (mean ± SD) and 1.440 ± 0.274 in eczema 
and non-eczema infants, respectively (p  =  0.482). The 
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Simpson index also reflected little discrepancy: averag-
ing 0.322 ± 0.080 for eczema infants and 0.339 ± 0.096 
for non-eczema infants (p = 0.871) (Fig. 1). The Shannon 
and Simpson indices, which were calculated at the genus 
level, also implicated no apparent differential microbial 
diversity between eczema and non-eczema infants (0.986 
p value for the Shannon test and 0.733 p value for the 
Simpson test) (Fig. 1).
Enriched bacterial residents in eczema and non‑eczema 
infants
Through LEfSe analysis, a total of 6 differentially 
enriched bacterial colonizers (5 in the eczema infants 
and 1 in the non-eczema infants) were identified (Fig. 2). 
Phylum Deinococcus_Thermus (0.003  ±  0.007  %, LDA 
score  =  2.947), class Deinococci (0.003  ±  0.007  %, 
LDA score  =  2.828), and order Deinococcales 








 Male 15 7
 Female 4 7
Feeding method 0.305
 Breastfeeding 9 10
 Formula feeding 10 4
Age (months) 0.541
 1–3 9 9
 3–6 10 5
Delivery mode 0.923
 Caesarean section 11 7



































Fig. 1 Gut microbial diversity in eczema and non-eczema infants. a Distribution of the Shannon and Simpson indices in infants with and without 
eczema with OTUs results. b Gut microbial diversity at the species level. The cyan and red represent non-eczema and eczema infants, respectively. 
























Fig. 2 Detection and distribution of biomarkers in eczema and non-eczema infants. a Biomarkers discovered by LEfSe analysis and their corre-
sponding LDA score are listed. Cyan and red represent non-eczema and eczema infants, respectively. b Relative abundance of biomarkers in eczema 
and non-eczema infants. The cyan and red represent non-eczema and eczema infants, respectively, and the circles with the larger diameter repre-
sent the higher abundance. In b, it appears that Bacteroidaceae was the primary biomarker responsible for the gut microbial difference between 
eczema and non-eczema infants
































Fig. 3 Gut microbial network in eczema and non-eczema infants younger than 6 months. The correlation analysis among gut bacteria was 
executed and the relationships whose r value was higher than 0.45 or lower than −0.35 were kept. The green and red edges represent the positive 
correlation and negative correlation, respectively. The diameter of the spots was proportional to the relative abundance. Most of the GM network 
in the non-eczema group was absent in the group with eczema, but the negative relationship between Enterobacteriaceae and Clostridiaceae 
remained. Meanwhile direct negative correlation between Bacteroidaceae and Unclassified Clostridiales was enhanced in the non-eczema group
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(0.002 ± 0.006 %, LDA score = 2.842) were enriched in 
infants with eczema (Fig. 2). Abundance of family Bacte-
roidaceae (10.355 ±  18.734  %, LDA score =  4.606) and 
Deinococcaceae (0.002  ±  0.006  %, LDA score  =  2.919) 
were significantly higher for infants with eczema as 
compared to the non-eczema samples (Fig.  2). Appar-
ent enrichment of specific bacterial colonizer was not 
detected at the genus level, partly due to the high similar-
ity of 16S rDNA V4-V5 region for some bacteria, includ-
ing Escherichia/Shigella and Citrobacter and Klebsiella 
and Enterobacter (Additional file 3).
Eczema and non‑eczema groups harbor distinctive gut 
microbial co‑abundance networks
For non-eczema infants, Clostridiaceae, Veillonellaceae, 
and Lactobacillaceae were the core nodes of the correla-
tion network (Fig.  3). Enriched Enterobacteriaceae was 
negatively correlated with Clostridiaceae (r  =  −0.459), 
while Veillonellaceae was positively correlated with Bac-
teroidaceae (r  =  0.494) and Unclassified Clostridiales 
(r = 0.485). The aforementioned networks seemed to be 
absent in eczema infants: Veillonellaceae was involved 
in a different correlation independently, and the direct 
correlation was found between Bacteroidaceae and 
Enterobacteriaceae (r = −0.570) and Bacteroidaceae and 
Unclassified Clostridiales (r = 0.800) (Fig. 3). The nega-
tive correlation between Clostridiaceae and Enterobacte-
riaceae had a tendency to be similar in both the eczema 
(r = 0 to 0.452) and the non-eczema infants (r = −0.459) 
(Fig. 3).
Discussion
This study mainly focused on the GM discrepancy 
between eczema and non-eczema infants under 
6 months of age in China. The results suggested a slightly 
lower microbial diversity in eczema infants, which dif-
fered from a prior report [3]. This was possibly attributed 
to the relative abundance discrepancy of GM between 
eczema and non-eczema infants, and immature GM 
showed no significant change.
At the genus level, it was difficult to distinguish Escher-
chia/Shigella from Citrobacter and Klebsiella from Enter-
obacter based on 16S rDNA V4-V5 region (Additional 
file 3). The confounded microbial composition analysis at 
the genus level was due to a high proportion of Escher-
chia/Shigella, Citrobacter, Klebsiella, and Enterobacter. 
At the family level, Bacteroidaceae and Deinococcaceae 
were more abundant in eczema infants. Prior reports 
demonstrated that increasing Bacteroides, which were 
classified into the family Bacteroidaceae, could promote 
the secretion of IL-6 and IL-23 in dendritic cells [13]. 
IL-6 and IL-23 are known to promote the differentiation 
of Th17 cells; the secretion of IL-17 by Th17 cells could 
trigger an inflammatory response and autoimmune 
diseases [13, 22]. Therefore, the association between 
increased Bacteroidaceae and eczema could be partly 
attributed to Bacteroides-related cytokines. The function 
of Deinococcaceae, which exhibited radio resistance and 
is normally found in soil [23], has seldom been reported 
in the human gut.
Another finding in this study was the distinctive GM 
co-abundance network between the two groups. For non-
eczema subjects, Clostridiaceae, Veillonellaceae, and Lac-
tobacillaceae correlated with other microbial colonizers. 
In eczema infants, the overall microbial linkage observed 
in non-eczema subjects was absent, and instead featured 
the core-node of Enterobacteriaceae, which included 
opportunistic pathogens such as Klebsiella, Salmonella, 
and Shigella. This may result in intense feedback from the 
host immune system. Combined with enriched Bacteroi-
daceae, which was previously documented to promote 
cytokines secretion [13, 22], eczema infants may have a 
hyperactive immune system.
Conclusions
Although this study furthers the understanding of GM 
involvement in infantile eczema development, there 
are some issues that still need to be resolved: detection 
of microbial interaction and discrepancy at lower taxo-
nomic levels; large cohort studies to confirm these find-
ings; and experimental studies to confirm the identified 
contributors. In summary, this work lays the foundation 
for a theoretical method of GM involvement in eczema 
development.
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